表紙
市場調查報告書

介入性脊椎設備的全球市場:2020年∼2024年

Global Interventional Spine Devices Market 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 422866
出版日期 內容資訊 英文 120 Pages
訂單完成後即時交付
價格
介入性脊椎設備的全球市場:2020年∼2024年 Global Interventional Spine Devices Market 2020-2024
出版日期: 2020年04月20日內容資訊: 英文 120 Pages
簡介

全球介入性脊椎設備市場在2020年∼2024年的預測期間內,預計將以10%的年複合成長率增長,達到23億1,000萬美元的規模。市場成長的主要因素有脊椎和骨骼疾病的發病率增加以及有利的給付方案。特別是,脊椎和骨骼疾病的發病率增加可能會推動市場的進一步增長。

本報告提供全球介入性脊椎設備市場相關調查分析,提供市場規模及成長率,市場趨勢,推動市場要素,課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

摘要整理

市場形勢

市場規模

  • 市場定義
  • 市場區隔分析
  • 2019年的市場規模
  • 市場預測:從2019年開始2024年的預測

波特的五力分析

各治療市場區隔

  • 市場區隔
  • 各治療比較:市場規模·預測(2019年∼2024年)
  • 經皮椎體成形術(骨水泥療法)
  • 球囊擴張椎體成形術
  • 射頻消融術
  • 其他
  • 各治療市場機會

客戶形勢

  • 概要

各地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模·預測(2019年∼2024年)
  • 北美
  • 歐洲
  • 亞太地區
  • 其他地區
  • 主要國家
  • 各地區的市場機會

成長要素,課題,及趨勢

  • 市場成長要素
  • 交易量的成長要素-需求主導型成長
  • 交易量的成長要素-供給主導型成長
  • 交易量的成長要素-外部要素
  • 交易量的成長要素-需求轉移到鄰近市場
  • 價格上升要素-通貨膨脹
  • 價格成長要素-從低價格單位轉變到高價格單位
  • 市場課題
  • 市場趨勢

業者情勢

  • 概要
  • 形勢的創新

供應商分析

  • 交易廠商
  • 供應商的市場定位
  • Abbott Laboratories
  • Alphatec Holdings Inc.
  • Globus Medical Inc.
  • Integra LifeSciences Corp.
  • Johnson & Johnson
  • Medtronic Plc
  • Nuvasive Inc.
  • RTI Surgical Holdings Inc.
  • Stryker Corp.
  • Zimmer Biomet Holdings Inc.

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: IRTNTR43079

Technavio has been monitoring the interventional spine devices market and it is poised to grow by $ 2.31 bn during 2020-2024 progressing at a CAGR of 10% during the forecast period. Our reports on interventional spine devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing number of incidences of spine and bone disorders and favourable reimbursement scenario. In addition, increasing number of incidences of spine and bone disorders is anticipated to boost the growth of the market as well.

The interventional spine devices market analysis includes procedure segment and geographic landscapes

Technavio's ‘ interventional spine devices market ’ is segmented as below:

By Procedure:

  • Vertebroblasty
  • Kyphoplasty radiofrequency ablation
  • Others

By Geographic Landscape:

  • North America
  • Europe
  • APAC
  • ROW

This study identifies the growing demand for MI and non-invasive procedures as one of the prime reasons driving the interventional spine devices market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our interventional spine devices market covers the following areas:

  • Interventional spine devices market sizing
  • Interventional spine devices market forecast
  • Interventional spine devices market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading interventional spine devices market vendors that include Abbott Laboratories, Alphatec Holdings Inc., Globus Medical Inc., Integra LifeSciences Corp., Johnson & Johnson, Medtronic Plc, Nuvasive Inc., RTI Surgical Holdings Inc., Stryker Corp., and Zimmer Biomet Holdings Inc.. Also, the interventional spine devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Other 1

  • Market segments
  • Comparison by Other1
  • Vertebroblasty - Market size and forecast 2019-2024
  • Kyphoplasty - Market size and forecast 2019-2024
  • Radiofrequency ablation - Market size and forecast 2019-2024
  • Others - Market size and forecast 2019-2024
  • Market opportunity by Other1

Customer landscape

  • Overview

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography

Drivers, Challenges, and Trends

  • Market drivers
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Volume driver - Demand shift in adjacent markets
  • Price driver - Inflation
  • Price driver - Shift from lower to higher priced units
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Abbott Laboratories
  • Alphatec Holdings Inc.
  • Globus Medical Inc.
  • Integra LifeSciences Corp.
  • Johnson & Johnson
  • Medtronic Plc
  • Nuvasive Inc.
  • RTI Surgical Holdings Inc.
  • Stryker Corp.
  • Zimmer Biomet Holdings Inc.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1.Key Finding 1
  • 2.Key Finding 2
  • 3.Key Finding 3
  • 4.Key Finding 5
  • 5.Key Finding 6
  • 6.Key Finding 7
  • 7.Key Finding 8
  • 8.Market in focus
  • 9.Parent market
  • 10.Market characteristics
  • 11.Offerings of vendors included in the market definition
  • 12.Market segments
  • 13.Global - Market size and forecast 2019 - 2024 ($ billion)
  • 14.Global market: Year-over-year growth 2019 - 2024 (%)
  • 15.Five forces analysis 2019 & 2024
  • 16.Bargaining power of buyers
  • 17.Bargaining power of suppliers
  • 18.Threat of new entrants
  • 19.Threat of substitutes
  • 20.Threat of rivalry
  • 21.Market condition - Five forces 2019
  • 22.Other1 placement - Market share 2019-2024 (%)
  • 23.Comparison by Other1
  • 24.Vertebroblasty - Market size and forecast 2019-2024 ($ billion)
  • 25.Vertebroblasty - Year-over-year growth 2019-2024 (%)
  • 26.Kyphoplasty - Market size and forecast 2019-2024 ($ billion)
  • 27.Kyphoplasty - Year-over-year growth 2019-2024 (%)
  • 28.Radiofrequency ablation - Market size and forecast 2019-2024 ($ billion)
  • 29.Radiofrequency ablation - Year-over-year growth 2019-2024 (%)
  • 30.Others - Market size and forecast 2019-2024 ($ billion)
  • 31.Others - Year-over-year growth 2019-2024 (%)
  • 32. Market opportunity by Other1
  • 33.Customer landscape
  • 34.Market share by geography 2019-2024 (%)
  • 35.Geographic comparison
  • 36.North America - Market size and forecast 2019-2024 ($ billion)
  • 37.North America - Year-over-year growth 2019-2024 (%)
  • 38.Europe - Market size and forecast 2019-2024 ($ billion)
  • 39.Europe - Year-over-year growth 2019-2024 (%)
  • 40.APAC - Market size and forecast 2019-2024 ($ billion)
  • 41.APAC - Year-over-year growth 2019-2024 (%)
  • 42.ROW - Market size and forecast 2019-2024 ($ billion)
  • 43.ROW - Year-over-year growth 2019-2024 (%)
  • 44.Key leading countries
  • 45.Market opportunity by geography ($ billion)
  • 46.Impact of drivers and challenges
  • 47.Vendor landscape
  • 48.Landscape disruption
  • 49.Industry risks
  • 50.Vendors covered
  • 51.Market positioning of vendors
  • 52.Abbott Laboratories - Overview
  • 53.Abbott Laboratories - Business segments
  • 54.Abbott Laboratories - Key offerings
  • 55.Abbott Laboratories - Key customers
  • 56.Abbott Laboratories - Segment focus
  • 57.Alphatec Holdings Inc. - Overview
  • 58.Alphatec Holdings Inc. - Business segments
  • 59.Alphatec Holdings Inc. - Key offerings
  • 60.Alphatec Holdings Inc. - Key customers
  • 61.Alphatec Holdings Inc. - Segment focus
  • 62.Globus Medical Inc. - Overview
  • 63.Globus Medical Inc. - Product and service
  • 64.Globus Medical Inc. - Key offerings
  • 65.Globus Medical Inc. - Key customers
  • 66.Globus Medical Inc. - Segment focus
  • 67.Integra LifeSciences Corp. - Overview
  • 68.Integra LifeSciences Corp. - Business segments
  • 69.Integra LifeSciences Corp. - Key offerings
  • 70.Integra LifeSciences Corp. - Key customers
  • 71.Integra LifeSciences Corp. - Segment focus
  • 72.Johnson & Johnson - Overview
  • 73.Johnson & Johnson - Business segments
  • 74.Johnson & Johnson - Key offerings
  • 75.Johnson & Johnson - Key customers
  • 76.Johnson & Johnson - Segment focus
  • 77.Medtronic Plc - Overview
  • 78.Medtronic Plc - Business segments
  • 79.Medtronic Plc - Key offerings
  • 80.Medtronic Plc - Key customers
  • 81.Medtronic Plc - Segment focus
  • 82.Nuvasive Inc. - Overview
  • 83.Nuvasive Inc. - Product and service
  • 84.Nuvasive Inc. - Key offerings
  • 85.Nuvasive Inc. - Key customers
  • 86.Nuvasive Inc. - Segment focus
  • 87.RTI Surgical Holdings Inc. - Overview
  • 88.RTI Surgical Holdings Inc. - Business segments
  • 89.RTI Surgical Holdings Inc. - Key offerings
  • 90.RTI Surgical Holdings Inc. - Key customers
  • 91.RTI Surgical Holdings Inc. - Segment focus
  • 92.Stryker Corp. - Overview
  • 93.Stryker Corp. - Business segments
  • 94.Stryker Corp. - Key offerings
  • 95.Stryker Corp. - Key customers
  • 96.Stryker Corp. - Segment focus
  • 97.Zimmer Biomet Holdings Inc. - Overview
  • 98.Zimmer Biomet Holdings Inc. - Business segments
  • 99.Zimmer Biomet Holdings Inc. - Key offerings
  • 100.Zimmer Biomet Holdings Inc. - Key customers
  • 101.Zimmer Biomet Holdings Inc. - Segment focus
  • 102.Currency conversion rates for US$
  • 103.Research Methodology
  • 104.Validation techniques employed for market sizing
  • 105.Validation techniques employed for market sizing
  • 106.Information sources
  • 107.List of abbreviations